Markers of COPD Exacerbations

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

July 25, 2022

Primary Completion Date

January 31, 2025

Study Completion Date

December 31, 2025

Conditions
COPDCOPD Exacerbation
Interventions
DIAGNOSTIC_TEST

Frequent assessment of biomarker panel

During the eight-week inpatient follow-up period there will be daily follow-up of respiratory symptoms, vitals and spirometry, and a thrice weekly collection of spontaneous sputum, nasal swabs and venous blood. These assessments will be repeated at acute worsening of respiratory symptoms at which a stool sample will also be collected.

Trial Locations (1)

6085 NM

RECRUITING

Ciro, Horn

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Center of Expertise for Chronic Organ Failure

OTHER